2 code implementations • Cancer Imaging 2024 • Elmira Yazdani, Najme Karamzadeh-Ziarati, Seyyed Saeid Cheshmi, Mahdi Sadeghi, Parham Geramifar, Habibeh Vosoughi, Mahmood Kazemi Jahromi, Saeed Reza Kheradpisheh
Prostate-specific membrane antigen (PSMA) PET/CT imaging is widely used for quantitative image analysis, especially in radioligand therapy (RLT) for metastatic castration-resistant prostate cancer (mCRPC).